Johnson & Johnson has announced a significant investment in heart care with a $13-billion deal to acquire Shockwave Medical, a company known for its innovative technology that helps open clogged arteries. The health care giant revealed that it will be paying $335 in cash for each share of Shockwave, a move that has already received approval from both companies' boards of directors.
Shockwave Medical specializes in intravascular lithotripsy, a cutting-edge technology that utilizes sonic pressure waves to crack calcium lesions in arteries, thereby restoring blood flow and enabling stenting. This technology is primarily used in the treatment of coronary artery and peripheral artery disease.
